Clinical Trial

Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy

Name: Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy — clinical trial record (NCT06972615)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

interventional study of intravesical chemotherapy and sistemic immunotherapy in NMIBC

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-29

Trial Details

NCT Number	NCT06972615
Lead Sponsor	BLATAM
Conditions	Non Muscle Invasive Bladder Cancer
Enrollment	37 participants
Start Date	2026-05-21
Primary Completion	2029-12-31 (estimated)
Study Completion	2030-06-15 (estimated)
Updated on ClinicalTrials.gov	2026-05-28